UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016286
Receipt number R000018893
Scientific Title Feasibility study of three months enteral nutrition after esophageal surgery
Date of disclosure of the study information 2015/01/21
Last modified on 2022/01/25 21:27:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of three months enteral nutrition after esophageal surgery

Acronym

FAST-ERAS Trial

Scientific Title

Feasibility study of three months enteral nutrition after esophageal surgery

Scientific Title:Acronym

FAST-ERAS Trial

Region

Japan


Condition

Condition

Thoracic esophageal cancer

Classification by specialty

Gastrointestinal surgery Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Feasibility of three months home enteral nutrition for patient who underwent radical esophagectomy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of the patients who completed the course

Key secondary outcomes

Body weight, BMI, serum albumin, prealbumin, total cholesterol, lymphocyte count, bioelectrical impedance method for body composition assessment, incidence of adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

ENEVO (Liquid for Enteral Use) 250ml in a day
90 days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1.Histlogically diagnosed esophageal cancer
2.Clinical stage I, II, III, IV
3.Curative resection (R0)
4.Retrosternal gastric tube reconstruction
5.Gastrotomy
6.Discharge
7.Life expectation >= 6 months
8.No preoperative treatment or only neoadjuvant treatment
9.Written informed consents

Key exclusion criteria

1.Clinically T4
2.Metastasisof distal organ without supraclavicular lymph node metastasis
3.Impossible of home enteral nutrition
4.Pregnant or woman of child bearing potential
5.Doctor's stop not to register to the study

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Tsubosa

Organization

Shizuoka Cancer Center

Division name

Division of Esophageal Surgery

Zip code

411-8777

Address

1007 Shiminagakubo Nagaizumi-cho Shizuoka, Japan

TEL

055-989-5222

Email

y.tsubosa@scchr.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Niihara

Organization

Kitasato University School of Medicine

Division name

Department of Upper Gastrointestinal Surgery

Zip code

252-0374

Address

1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa

TEL

042-778-8111

Homepage URL


Email

mniihara@med.kitasato-u.ac.jp


Sponsor or person

Institute

Shizuoka Industrial Foundation Pharma Valley Center

Institute

Department

Personal name



Funding Source

Organization

Shizuoka Industrial Foundation Pharma Valley Center

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shizuoka Cancer Center Certified Review Board

Address

1007 Shiminagakubo Nagaizumi-cho Shizuoka, Japan

Tel

055-989-5222

Email

rinsho_office@scchr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 21 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172505/pdf/10388_2020_Article_803.pdf

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172505/

Number of participants that the trial has enrolled

24

Results

This study enrolled 24 post-esophagectomy
patients between February 2015 and September 2016. Twenty patients were administered 70% or more of the planned nutrient, with 83% of the patients completing the nutritional
intervention procedure.

Results date posted

2022 Year 01 Month 25 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 01 Month 21 Day

Baseline Characteristics

There were 18 males and 6 females, with a
mean age of 61.8 years.
Mean body weight were 57.3 kg. Among the
participants, 7 (29.2%) had stage I disease, 4 (16.7%) had stage II disease, and 13
(54.2%) had stage III disease.

Participant flow

Between February 2015 and September 2016, 24 esophagectomy patients were enrolled in this study.

Adverse events

All 24 patients could be assessed for AEs
during the intervention. There was no grade 3/4 AE. Grade 2 dermatitis caused by the
tape used to fix the tube in place occurred
in 1 patient (4.2%). Grade 1 diarrhea
occurred in 1 patient (1.2%). Both AEs
improved within 2 months.

Outcome measures

The primary outcome measures in this pilot
study were chosen to determine whether or
not the planned home supplemental enteral
tube feeding nutrition would be feasible.
The total planned dose for the whole period was 22,500 mL (27,000 kcal) in 90 cans of
Enevo.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 12 Month 17 Day

Date of IRB

2014 Year 12 Month 08 Day

Anticipated trial start date

2015 Year 01 Month 21 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 20 Day

Last modified on

2022 Year 01 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018893


Research Plan
Registered date File name
2022/01/25 FULL PROTOCOL 改4.pdf

Research case data specifications
Registered date File name
2022/01/25 FULL PROTOCOL 改4.pdf

Research case data
Registered date File name
2022/01/25 10388_2020_Article_803.pdf